FDA Inspection
Zhejiang Supor Pharmaceuticals Co., Ltd.Zhejiang Supor Pharmaceuticals Co., Ltd. – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns Zhejiang Supor Pharmaceuticals Co., Ltd., with an inspection on March 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6cebbc00-7485-4c48-9939-d7d6e1620b87
Inspection Facts
- Inspection number
- 1265345
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Supor Pharmaceuticals Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 1, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Supor Pharmaceuticals Co., Ltd.
- FDA Inspection 1068562 - 2018-06-01
- FDA Inspection 966186 - 2016-03-25
- FDA Inspection 849836 - 2013-09-20
- FDA Inspection 707175 - 2010-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.